

(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has granted priority review for its immunotherapy drug Imfinzi for ...


(Alliance News) - AstraZeneca PLC on Friday said its therapy for the treatment of chronic obstructive pulmonary disease in adults has received a posit...


FTSE 100 up 0.9%, FTSE 250 up 0.6% *


(Alliance News) - AstraZeneca PLC on Thursday said its investigational complement C5 inhibitor gefurulimab showed statistically significant results in...


(Sharecast News) - AstraZeneca announced on Thursday that its investigational treatment 'gefurulimab' achieved statistically significant and clinicall...


FTSE 100 up 0.4%, FTSE 250 up 0.4% *


(Alliance News) - European stocks climbed on Wednesday, boosted by hopes of further progress in trade talks after the US struck a deal with Japan.